Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials.
52W Range
15thpctl
Volume
0.34×avg
Market Cap
432.21MUSD
P/E Ratio
-5.8TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Compass Therapeutics, Inc.
CMPXNASDAQ Capital Market·USD·Closed
Compass Therapeutics, Inc.
CMPXNASDAQ·USD·Closed
$2.40
−4.76%
$2.40
−$0.12 (4.76%)
52W Range
15thpctl
Volume
0.34×avg
Mkt Cap
432.21MUSD
P/E
-5.8TTM
Div Yield
–ann
CMPX: Compass Therapeutics, Inc. Stock Analysis | finqOS
